Silence Therapeutics said that its executive chairman Jerry Randall has stepped down from his position at the company.
He was replaced with Simon Sturge, formerly a non-executive director of the company. Sturge, however, will serve as chairman in a non-executive capacity, Silence said.
Additionally, Annie Cheng has been promoted from director of corporate development to chief operating officer.
Klaus Giese has also retired as Silence's CSO, and will be replaced by Jorg Kaufmann. Both Geise and Kaufmann were co-founders of Silence predecessor company Atugen.